See all information on COVID-19, situation updates, risk assessments, questions and answers, latest evidence, surveillance and laboratory guidance and how to protect yourself and others.
This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 29 June−5 July 2024 and includes updates on SARS-CoV-2 variant classification, swine influenza, an overview of respiratory virus epidemiology in the EU/EEA, parvovirus infection, avian influenza, West Nile virus infections, mass gatherings and botulism.
This report collects all COVID-19 long-term care facilities (LTCF) data reported to ECDC from 2021 and concludes the EU/EEA LTCF COVID-19 specific surveillance data collection from 2021-2023.
This report presents pooled COVID-19 vaccine effectiveness (VE) estimates for the first, second and third booster doses (compared to complete primary vaccination with no booster) against hospitalisation due to COVID-19 and COVID-19-related death in resident populations ≥50 years of age living in the community.
Significant disruptions were observed in HIV-specific services, particularly for in-clinic and community-based HIV testing, according to the ECDC report "The impact of the COVID-19 pandemic on the HIV response in Europe and Central Asia."
At the request of the Slovenian National Institute of Public Health (NIJZ), ECDC designed and facilitated an After-Action review (AAR), focusing on the response to the COVID-19 pandemic.
ECDC regularly assesses new evidence on variants detected through epidemic intelligence, rules-based genomic variant screening or other scientific sources.
This report provides a record of the impact noted by countries on HIV services and monitoring capacity which can be used retrospectively to better understand the effects of the COVID-19 pandemic on the HIV situation in the European Region.